Natera reports outcomes from study of MRD test for soft tissue and bone sarcomas
Natera has announced findings from a study evaluating its Signatera in individuals with soft tissue and bone sarcomas. The post Natera reports outcomes from study of MRD test for soft tissue and bone sarcomas appeared first on Medical Device Network.

The post Natera reports outcomes from study of MRD test for soft tissue and bone sarcomas appeared first on Medical Device Network.